About Cradle
Cradle is a company based in Delft (Netherlands) founded in 2021 by Stef Van Grieken and Jelle Prins. It operates as a SaaS (Software-as-a-Service) and Subscription Services. Cradle has raised $102.71 million across 3 funding rounds from investors including IVP, Index Ventures and Kindred. Cradle offers products and services including Cradle AI Platform. Cradle operates in a competitive market with competitors including Nimbus Therapeutics, EvolutionaryScale, Evozyne, Profluent Bio and Frontier Medicines, among others.
- Headquarter Delft, Netherlands
- Founders Stef Van Grieken, Jelle Prins
- SectorsHealthcareTechnology
- Email••••••••
- Website cradle.bio
- Social LinkedIn
- Total Equity Funding$102.71M (USD)
in 3 rounds
- Latest Funding Round$73M (USD), Series B
Nov 2024
- InvestorsIVP
& 6 more
Products & Services of Cradle
Cradle offers a comprehensive portfolio of products and services, including Cradle AI Platform.
AI platform used to optimize protein design efficiently.
Funding Insights of Cradle
Cradle has successfully raised a total of $102.71M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $73 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $102.71M
- Total Rounds 3
- Last Round Series B — $73M
- First Round $5.71M
(Nov 2022)
- Investors Count 7
All 3 funding rounds of Cradle with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2024 | $73M | Series B | – | IVP | |
| Nov 2023 | $24M | Series A | – | Index Ventures | |
| Nov 2022 | $5.71M | Seed | – | Index Ventures, Kindred Capital |
7 investors in total: 3 institutional and 4 angel.
Investors in Cradle
Cradle has secured backing from 7 investors, including venture fund and angel investors. Prominent investors backing the company include IVP, Index Ventures and Kindred.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth in technology companies is supported through venture capital. | – | ivp.com | Menlo Park, United States | |
Venture capital investments in technology startups and entrepreneurs. | – | indexventures.com | - | |
Venture capital funding is offered to pre-seed and seed startups. | 2015 | kindredcapital.vc | - | |
CG Chris Gibson | Angel investor and entrepreneur, co-founder of EasyRewardz, focused on tech startups | – | unknown_204939e74c47436bb | - |
TG Tom Glocer | Former CEO of Thomson Reuters, active angel investor in tech startups. | – | unknown_29d6164b738345649 | - |
FS Feike Sijbesma | - | – | unknown_f61531c8f83b42d8a | - |
EL Emily Leproust | CEO of Twist Bioscience, pioneering synthetic biology, active angel investor | – | unknown_c7cb1a4812ac49be9 | - |
Investor details for Cradle
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cradle
17 people are tracked at Cradle (7 in leadership, 10 in team).
| Name | Role | Group |
|---|---|---|
Stef Van Grieken | Co-Founder & CEO | Leadership |
Jelle Prins | Co-Founder | Leadership |
Daniel Danciu | CTO | Leadership |
Harmen van Rossum | Co-Founder | Leadership |
Luba (Liubov) Protopopova 🇺🇦 | Chief Operating Officer | Leadership |
Elise de Reus | Co-founder, Partnerships | Leadership |
Sam Partovi | Chief Commercial Officer (cco) | Leadership |
Travis Glennon | Account Executive | Team |
Emanuele Monza | Customer Success Manager | Team |
Franziska Geiger | Machine Learning Engineer and employee #1 | Team |
Ena Škopelja | Software Engineer | Team |
Adam Weber | Software Engineer | Team |
Wallis Margraff | Global Partnership Manager | Team |
Sytske Besemer | User Experience Researcher | Team |
Robbert van Ginkel | Software Engineer | Team |
Max Henningsson | Design | Team |
Mike Niekerk | Commercial Lead EMEA | Team |
Complete people profiles for Cradle
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cradle
3 dated milestones of Cradle across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Cradle is founded.
- Funding First funding round of $5.7M.
- Funding Latest funding round, Series B, of $73.0M.
Competitors of Cradle
Cradle operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nimbus Therapeutics, EvolutionaryScale, Evozyne, Profluent Bio and Frontier Medicines, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nimbustx.com | 2009 | Cambridge, United States | $685M | 81 | Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed. | |
| evolutionaryscale.ai | 2023 | New York, United States | $142M | – | Provider of an AI models for protein design | |
| evozyne.com | 2020 | Chicago, United States | $144.37M | – | Developer of proteins using protein engineering technology | |
| profluent.bio | 2022 | Berkeley, United States | $44M | – | An AI-based protein design platform is provided for drug discovery. | |
| frontiermeds.com | 2018 | San Francisco, United States | $235.5M | 115 | Bioinformatics platform is developed for drug discovery and chemoproteomics. | |
| eikontx.com | 2019 | Hayward, United States | $1.16B | – | Protein dynamics are tracked and measured for drug discovery processes. | |
| entactbio.com | 2022 | Watertown, United States | $120.9M | – | Drugs are developed to enhance functions of beneficial proteins. |
Detailed competitors of Cradle
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cradle
The website of Cradle (cradle.bio) receives about 40.6K visits a month.
- Monthly visits40.6K
▼ 9.6% vs previous month
Websites whose visitors overlap most with Cradle. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| linkedin.com | 100% | 1.9B | #18 | View details | |
| google.com | 100% | 85.8B | #1 | View details | |
| cradl.ai | 44% | 9.7K | #1,934,037 | View details |
Latest news on Cradle
Complete news archive for Cradle
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Cradle
10 companies that operate in the same segment as Cradle (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cradle
Cradle was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Cradle is headquartered in Delft, Netherlands. It is registered at Delft, South Holland, Netherlands.
Stef Van Grieken is the current CEO of Cradle. They have also founded this company.
Cradle is a funded company, having raised a total of $102.71M across 3 funding rounds to date. The company's 1st funding round was a Seed of $5.71M, raised on Nov 2022.
Cradle is engaged in developing AI-based software for protein engineering. Solutions are provided to biopharma and industrial bio sectors. The platform is designed to generate and optimize protein candidates, reducing experimental timelines. Applications are supported across therapeutics, agricultural solutions, and food ingredients. Data privacy and security are prioritized with bank-grade protection. Models are continuously improved through proprietary lab testing in Amsterdam.
Cradle's top competitors include Nimbus Therapeutics, Profluent Bio and Eikon.
Cradle offers Cradle AI Platform.
Cradle has 7 investors. Key investors include IVP, Index Ventures, Kindred, Chris Gibson, and Tom Glocer.